Literature DB >> 2736545

Epithelial ovarian cancer and the ability to conceive.

A S Whittemore1, M L Wu, R S Paffenbarger, D L Sarles, J B Kampert, S Grosser, D L Jung, S Ballon, M Hendrickson, J Mohle-Boetani.   

Abstract

Relationships between ovarian cancer and ability to conceive were explored in a case-control study of 188 women with histologically confirmed epithelial ovarian cancer and 539 control women in the San Francisco Bay Area. Control women consisted of two groups: those hospitalized without cancer, matched to cases by age, race, and hospital of diagnosis (n = 280); and those selected from the general population by random digital dialing, matched to cases by age, race, and telephone prefix (n = 259). Ovarian cancer risk among nulliparous (but not parous) women was positively associated with a history of unsuccessful attempts to conceive, of physician-diagnosed infertility, and of doubts about ability to conceive. Among all women, risk increased with increasing years of unprotected intercourse (P value for trend = 0.02). Risk among women having 10 or more yr of unprotected intercourse was 1.8 relative to that among women having less than 2 such yr (P = 0.01). This association was independent of parity, oral contraceptive use, and estimated years of ovulation, each associated with ovarian cancer. Further, duration of unprotected intercourse combined multiplicatively with each of these latter characteristics in increasing ovarian cancer risk. For example, while cancer risk exhibited a 2-fold range from lowest to highest years of unprotected intercourse and a 4-fold range from lowest to highest years of ovulation, risk among women in the highest joint category of these characteristics was 8 times that of women in the lowest category. We believe that some abnormality of ovulation that reduces the likelihood of conception plays a role in epithelial ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

Review 2.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

3.  Fertility preservation for cancer patients: a review.

Authors:  Tosin Ajala; Junaid Rafi; Peter Larsen-Disney; Richard Howell
Journal:  Obstet Gynecol Int       Date:  2010-03-31

Review 4.  Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection.

Authors:  Sima Chaudhari; Satyajit Dey Pereira; Meshach Asare-Warehene; Ritam Naha; Shama Prasada Kabekkodu; Benjamin K Tsang; Kapaettu Satyamoorthy
Journal:  J Ovarian Res       Date:  2021-02-25       Impact factor: 4.234

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.